Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

Clinical trial NCT07079735 · RECRUITING

Trial details

NCT number: NCT07079735
Sponsor: Columbia University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

CMV Viremia Heart Transplant Infection Heart Transplant Failure and Rejection

Start date: 2025-09-12
Primary completion: 2028-01-17
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.